drugset / Trial / NCT02821533
Chemoembolization for Hepatocellular Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
The aim of the current study is to study the safety and effectiveness of TACE using a high dose of cisplatin for treatment of HCC. It is hypothesized that the formulation is safe and it improves the therapeutic effect of conventional TACE.
Timeline
- Start
- 2012-02
- Primary completion
- 2017-08
- Completion
- 2017-08
Outcome
Outcome not reported
Stopped (Enrollment): “Poor case accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cisplatin | Other / unclassified | 100 mg | Other |